EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

BJU International

ISSN 1464-4096 · Wiley

Latest articles

  1. Safety and feasibility of telesurgical robot assisted radical prostatectomy: prospective pilot study

    Geert De Naeyer, Edoardo Beatrici, Attilio Barretta, Nicola Frego, Natali Rodriguez Peñaranda, Francesco Pepillo, Alessio Guidotti, Mario de Angelis, Francesco Cei, Claudio Brancelli, Vincenzo Cavarra, Pietro Pasquini, Federico Lavagno, Niki Rashidian, Francesco Prata, Valerio Santarelli, Nicolas Carl, Frederiek D'Hondt, Pieter De Backer, Ruben De Groote, Edward Lambert, Alexandre Mottrie

    Published: 2026-12DOI: 10.1111/bju.70430

  2. The PART randomised trial protocol: Partial Ablation versus Radical Treatment for prostate cancer

    Richard J. Bryant, Tom Leslie, Marc Laniado, Abhishek Sharma, Alistair Grey, John Withington, Christopher Blick, Edward Streeter, Sanjeev Kotwal, Oliver Hulson, William Cross, Daniel W. Good, Altan Omer, Taimur T. Shah, Nishant Bedi, Luke Stroman, Caroline Moore, Prasanna Sooriakumaran, Hashim U. Ahmed, Simon F. Brewster, Vicki S. Barber, Aimi Hewitt, Clare Calvert, Jessica Scaife, Derek Shepherd, Filipa Landeiro, Jane Wolstenholme, Philip Camilleri, Clare Verrill, Shelagh Lovell, Martin Pirkl, Fergus Gleeson, Roxanne Williams, Jo Cook, Catherine R. Holt, Martyn Hill, Jonathan Cook, James Radford, Ioana R. Marian, Ruth Macpherson

    Published: 2026-12DOI: 10.1111/bju.70448

Volumes

2026 · 3852025 · 4572024 · 3462023 · 2912022 · 3162021 · 2942020 · 3302019 · 4062018 · 3902017 · 4022016 · 4282015 · 3952014 · 4282013 · 6262012 · 9652011 · 8572010 · 7442009 · 7752008 · 7942007 · 7142006 · 7772005 · 7262004 · 7532003 · 6752002 · 5662001 · 4792000 · 5981999 · 515

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.